Summit Therapeutics (NASDAQ:SMMT – Get Free Report) and Purple Biotech (NASDAQ:PPBT – Get Free Report) are both healthcare companies, but which is the better business? Earnings and ValuationThis table compares Summit Therapeutics and Purple Biotech”s top-line revenue, earnings per share and valuation. Comparatively, 3.0% of Purple Biotech shares are owned by insiders. Net Margins Return on Equity Return on Assets Summit Therapeutics N/A -168.94% -141.92% Purple Biotech N/A -136.79% -100.38%Analyst RecommendationsThis is a summary of current ratings and recommmendations for Summit Therapeutics and Purple Biotech, as reported by MarketBeat.com. Given Purple Biotech’s higher probable upside, analysts plainly believe Purple Biotech is more favorable than Summit Therapeutics.